Listar por tema "cobalt"

Ordenar por:Orden:Resultados:

  • Sharma, S.; Gralla, J.; Ordonez, J. G.; Hurtado, M. E.; Swenson, E. R.; Schoene, R. B.; Kelly, J. P.; Callacondo, D.; Rivard, C.; Roncal-Jimenez, C.; Sirota, J.; Fuquay, R.; Jackson, B. P.; Swenson, K. E.; Johnson, R. J.; Hurtado, A.; Escudero, E. (Elsevier, 2017)
    Patients suffering from chronic mountain sickness (CMS) have excessive erythrocytosis. Low level cobalt toxicity as a likely contributor has been demonstrated in some subjects. We performed a randomized, placebo controlled ...
  • Hurtado Arestegui, A.; Fuquay, R.; Sirota, J.; Swenson, E.R.; Schoene, R.B.; Jefferson, J.A.; Chen, W.; Yu, X.-Q.; Kelly, J.P.; Johnson, R.J.; Escudero, E. (American Society of Nephrolog, 2011)
    More than 140 million people live permanently at high altitude (>2400 m) under hypoxic conditions that challenge basic physiology. Here we present a short historical review of the populating of these regions and of evidence ...
  • Sheen Cortavarria, Patricia; Ferrer, P.; Gilman, Robert Hugh; Christiansen, G.; Moreno-Román, P.; Gutiérrez, A.H.; Sotelo, J.; Evangelista, W.; Fuentes, P.; Rueda, D.; Flores, M.; Olivera, P.; Solis, J.; Pesaresi, A.; Lamba, D.; Zimic-Peralta, Mirko Juan (American Society of Tropical Medicine and Hygiene, 2012)
    Pyrazinamidase of Mycobacterium tuberculosis catalyzes the conversion of pyrazinamide to the active molecule pyrazinoic acid. Reduction of pyrazinamidase activity results in a level of pyrazinamide resistance. Previous ...

Buscar en el Repositorio

Listar

Panel de Control